Breaking News

First public disclosure of data on clinical candidate NKTR-358, a First-in-Class Regulatory T Cell Stimulator to be presented at WCI2017 by Nektar Therapeutics.



For Speakers

Your presentations should be formatted with a 16:9 (Widescreen) ratio to ensure optimal viewing. You are encouraged to download our template to use for your presentation: WCI 2017 Presentation Template